Co-occurrence of inversion 16 and trisomy 22 cytogenetic abnormalities in a relapse phase acute non-lymphocytic leukemia case.
Acute non-lymphocytic leukemia is characterized by excessive accumulation of immature non lymphocytic bone marrow precursor cells in the marrow itself, and in peripheral blood. Here, a 23 year-old female patient with acute nonlymphocytic leukemia with inversion 16 and trisomy 22 cytogenetic findings...
| Published in: | Turkiye Klinikleri Journal of Medical Sciences Vol. 30; no. 6; pp. 2037 - 2041 |
|---|---|
| Main Authors: | , , , , |
| Format: | case study pictorial Journal Article |
| Published: |
Turkiye Klinikleri
Dec2010
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104812880&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104812880 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13000292 1VOP jtl: Turkiye Klinikleri Journal of Medical Sciences issn: 13000292 maglogo: N pubinfo: dt: Dec2010 vid: 30 iid: 6 pid: 67298 pub: Turkiye Klinikleri artinfo: ui: 104812880 104812880 2010938027 10.5336/medsci.2008-10249 104812880 ppf: 2037 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Co-occurrence of inversion 16 and trisomy 22 cytogenetic abnormalities in a relapse phase acute non-lymphocytic leukemia case. aug: au: Kozan, Salih Ates, Omer Güran, Sefik Bahçe, Muhterem Beyan, Cengiz sug: subj: Aneuploidy Leukemia, Myeloid Familial and Genetic Adult Female Adult: 19-44 years Female ab: Acute non-lymphocytic leukemia is characterized by excessive accumulation of immature non lymphocytic bone marrow precursor cells in the marrow itself, and in peripheral blood. Here, a 23 year-old female patient with acute nonlymphocytic leukemia with inversion 16 and trisomy 22 cytogenetic findings is presented. As known, inversion 16 is generally related to acute myeloid leukemia M4 subtype. Trisomy 22 which represents poor prognosis is generally reported with inversion 16 in acute myeloid leukemia. Our case was treated with idarubicin and cytosine arabinoside at her initial diagnosis phase two years ago. In the relapse phase, trisomy 22 and inversion 16 was found sixteen months later. After the idarubicin and cytosine arabinoside treatment, blastic cell ratio was found to be 9.8% and myelosuppression occurred. This finding represents the necessity of detailed cytogenetic and molecular cytogenetic analyses in leukemia cases in initial diagnosis and treatment phases for predicting the prognosis. pubtype: Academic Journal doctype: case study pictorial Journal Article ougenre: Article language: Turkish refInfo: holdings: @attributes: islocal: N |
|---|